Early Multicenter Experience With the Neuroform Atlas Stent: Feasibility, Safety, and Efficacy

Stretched and fractured Neuroform Atlas® stent during a stent‑assisted coil embolization: A case report

“…The procedure-related major adverse events and thromboembolic complications were acceptable, and most of the literature showed very high rates of technical success (Table I) . However, a few cases were reported with suboptimal deployment in unexpected locations and stent migration during the procedure (2,(5)(6)(7)(8)(9)(10)(11)(12)(13)(14). The suboptimal stent deployment occurred because of the microcatheter's sudden uncontrolled movement to the proximal part of the target artery during the opening and deployment of the stent.…”

“…Recently published prospective trials showed the efficacy and safety of Neuroform Atlas ® stents in treating IA with an excellent rate of procedure success and acceptable procedure-related complications (2)(3)(4). Among the procedural difficulties, several cases have been reported where stent migration or stent deployment in unexpected landing sites occurred during the procedure (2,(5)(6)(7)(8)(9)(10)(11)(12)(13)(14). Fracture and deformation of intracranial stents have rarely been reported.…”

Clipping Could Be the Best Treatment Modality for Recurring Anterior Communicating Artery Aneurysms Treated Endovascularly

“…[27][28][29] Despite that, the past 2 decades have witnessed a spur in the development of coils, microwires, microcatheters, and stents, thereby allowing enhanced tractability, conformability, and improved deployment accuracy. [27][28][29][30] In addition, the ability to place a 3-to 4.5-mm diameter stent using an 0.017-in catheter allowed interventionalists to push the envelope and have the upper hand in distal and cross-circulation approaches. 30 In our series, adjunctive techniques as the initial modality of treatment were used only in 13.3% of the entire cohort (10.9% balloon-assisted and 2.4% stent-assisted).…”

“…[27][28][29][30] In addition, the ability to place a 3-to 4.5-mm diameter stent using an 0.017-in catheter allowed interventionalists to push the envelope and have the upper hand in distal and cross-circulation approaches. 30 In our series, adjunctive techniques as the initial modality of treatment were used only in 13.3% of the entire cohort (10.9% balloon-assisted and 2.4% stent-assisted). An episode of SAH puts a patient at 22-fold higher risk of rebleeding compared with the general population.…”